News Headlines Article

FDA warns Pfizer for lax oversight of drug study
USA Today

Federal regulators say the drugmaker Pfizer has failed to correct problems with its testing procedures that resulted in overdoses for more than two dozen patients during a company trial. The Food and Drug Administration issued a warning letter saying Pfizer is not properly monitoring physicians testing an experimental medication, which the agency did not name. A Pfizer spokeswoman said the drug is Geodon, which the company is studying for children with bipolar disorder.